Form 8-K - Current report:
SEC Accession No. 0001193125-26-029514
Filing Date
2026-01-29
Accepted
2026-01-29 16:37:55
Documents
14
Period of Report
2026-01-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d61153d8k.htm   iXBRL 8-K 30863
2 EX-99.1 d61153dex991.htm EX-99.1 9934
6 GRAPHIC g61153g0129195708066.jpg GRAPHIC 4210
  Complete submission text file 0001193125-26-029514.txt   167036

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lxrx-20260129.xsd EX-101.SCH 2842
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrx-20260129_lab.xml EX-101.LAB 17992
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrx-20260129_pre.xml EX-101.PRE 11255
17 EXTRACTED XBRL INSTANCE DOCUMENT d61153d8k_htm.xml XML 3685
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 26578717
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)